Yerem Yeghiazarians, M.D.

Yerem Yeghiazarians, M.D. Co-Founder, CEO, Board Member.

Yerem Yeghiazarians, M.D., is Co-Founder and Chief Executive Officer of Soley Therapeutics. A clinician scientist with more than two decades of experience in cardiology, stem cell biology, and translational research, he leads Soley’s biology-first discovery strategy and guides the company’s evolution from foundational science into a clinical-stage organization. Before founding Soley, Dr. Yeghiazarians served as […]

Kurosh Ameri, Ph.D.

Kurosh Ameri, Ph.D. Co-Founder, CSO, Board Member.

Kurosh Ameri, Ph.D., is Co-Founder and Chief Scientific Officer of Soley Therapeutics. A molecular biologist and multidisciplinary researcher with deep expertise in cellular stress sensing, he leads the scientific direction of Soley’s platform and its integration of high-resolution cell-state biology with scalable discovery technologies. Before founding Soley, Dr. Ameri’s research helped establish the scientific foundation […]

Paul Woodard, M.D.

Paul Woodard, M.D. Chief Medical Officer.

Dr. Woodard is a pediatric hematologist-oncologist and stem cell transplant physician. He has more than 20 years of expertise in hematology and oncology clinical research and clinical trials. He has been responsible for trials in multiple solid tumor types and in malignant and benign hematologic disorders. He has developed different therapeutic modalities, including cancer immunotherapies, […]